Tags

Type your tag names separated by a space and hit enter

Invasive pneumococcal disease in Australia, 2009 and 2010.
Commun Dis Intell Q Rep. 2015 Jun 30; 39(2):E265-79.CD

Abstract

Enhanced surveillance for invasive pneumococcal disease (IPD) was conducted in all Australian states and territories in 2009 and 2010 with comprehensive comparative data available since 2002. There were 1,556 cases of IPD notified to the National Notifiable Diseases Surveillance System in Australia in 2009, a notification rate of 7.2 cases per 100,000 population. In 2010 there were 1,640 cases, a notification rate of 7.4 cases per 100,000. The overall rate of IPD in Indigenous Australians was almost 6 times the rate in non-Indigenous Australians in both 2009 and 2010. In 2009 and 2010, notification rates of IPD caused by serotypes included in the 7-valent pneumococcal conjugate vaccine (7vPCV) continued to decrease across all age groups. Rates of IPD caused by non-7vPCV serotypes continued to show an increasing trend in both Indigenous and non-Indigenous children aged less than 5 years. In Indigenous adults (≥50 years), rates of IPD caused by both 23-valent pneumococcal polysaccharide vaccine (23vPPV) serotypes and non-23vPPV serotypes continued to show an overall increase, particularly in 2010. There were 110 deaths attributed to IPD in 2009 and 137 in 2010, although it should be noted that deaths may be under-reported. The number of invasive pneumococcal isolates with reduced penicillin susceptibility remained low and reduced susceptibility to third generation cephalosporins was rare.

Authors+Show Affiliations

Vaccine Preventable Diseases Surveillance Section, Department of Health, Canberra, Australian Capital Territory.Vaccine Preventable Diseases Surveillance Section, Department of Health, Canberra, Australian Capital Territory.Communicable Diseases Prevention Unit, Department of Health and Human Services, Hobart, Tasmania.Vaccine Preventable Diseases Surveillance Section, Department of Health, Canberra, Australian Capital Territory.No affiliation info available

Pub Type(s)

Historical Article
Journal Article

Language

eng

PubMed ID

26234260

Citation

Bareja, Chritina, et al. "Invasive Pneumococcal Disease in Australia, 2009 and 2010." Communicable Diseases Intelligence Quarterly Report, vol. 39, no. 2, 2015, pp. E265-79.
Bareja C, Toms C, Lodo K, et al. Invasive pneumococcal disease in Australia, 2009 and 2010. Commun Dis Intell Q Rep. 2015;39(2):E265-79.
Bareja, C., Toms, C., Lodo, K., & de Kluyver, R. (2015). Invasive pneumococcal disease in Australia, 2009 and 2010. Communicable Diseases Intelligence Quarterly Report, 39(2), E265-79.
Bareja C, et al. Invasive Pneumococcal Disease in Australia, 2009 and 2010. Commun Dis Intell Q Rep. 2015 Jun 30;39(2):E265-79. PubMed PMID: 26234260.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Invasive pneumococcal disease in Australia, 2009 and 2010. AU - Bareja,Chritina, AU - Toms,Cindy, AU - Lodo,Kerryn, AU - de Kluyver,Rachel, AU - ,, Y1 - 2015/06/30/ PY - 2015/8/4/entrez PY - 2015/8/4/pubmed PY - 2016/3/5/medline SP - E265 EP - 79 JF - Communicable diseases intelligence quarterly report JO - Commun Dis Intell Q Rep VL - 39 IS - 2 N2 - Enhanced surveillance for invasive pneumococcal disease (IPD) was conducted in all Australian states and territories in 2009 and 2010 with comprehensive comparative data available since 2002. There were 1,556 cases of IPD notified to the National Notifiable Diseases Surveillance System in Australia in 2009, a notification rate of 7.2 cases per 100,000 population. In 2010 there were 1,640 cases, a notification rate of 7.4 cases per 100,000. The overall rate of IPD in Indigenous Australians was almost 6 times the rate in non-Indigenous Australians in both 2009 and 2010. In 2009 and 2010, notification rates of IPD caused by serotypes included in the 7-valent pneumococcal conjugate vaccine (7vPCV) continued to decrease across all age groups. Rates of IPD caused by non-7vPCV serotypes continued to show an increasing trend in both Indigenous and non-Indigenous children aged less than 5 years. In Indigenous adults (≥50 years), rates of IPD caused by both 23-valent pneumococcal polysaccharide vaccine (23vPPV) serotypes and non-23vPPV serotypes continued to show an overall increase, particularly in 2010. There were 110 deaths attributed to IPD in 2009 and 137 in 2010, although it should be noted that deaths may be under-reported. The number of invasive pneumococcal isolates with reduced penicillin susceptibility remained low and reduced susceptibility to third generation cephalosporins was rare. SN - 1445-4866 UR - https://www.unboundmedicine.com/medline/citation/26234260/Invasive_pneumococcal_disease_in_Australia_2009_and_2010_ L2 - https://www.health.gov.au/internet/main/publishing.nsf/Content/cda-cdi3902h.htm DB - PRIME DP - Unbound Medicine ER -